KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Cash (2016 - 2025)

Historic Change in Cash for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Gilead Sciences' Change in Cash fell 340.11% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 44289.99%. This contributed to the annual value of $3.9 billion for FY2024, which is 48038.63% up from last year.
  • As of Q3 2025, Gilead Sciences' Change in Cash stood at $2.2 billion, which was down 340.11% from -$2.8 billion recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Change in Cash peaked at $5.0 billion during Q4 2024, and registered a low of -$2.8 billion during Q2 2025.
  • For the 5-year period, Gilead Sciences' Change in Cash averaged around $70.2 million, with its median value being $1.0 million (2023).
  • Data for Gilead Sciences' Change in Cash shows a peak YoY increase of 22630000.0% (in 2024) and a maximum YoY decrease of 35338.54% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Gilead Sciences' Change in Cash stood at $976.0 million in 2021, then dropped by 26.95% to $713.0 million in 2022, then crashed by 46.7% to $380.0 million in 2023, then soared by 1203.95% to $5.0 billion in 2024, then plummeted by 55.86% to $2.2 billion in 2025.
  • Its last three reported values are $2.2 billion in Q3 2025, -$2.8 billion for Q2 2025, and -$2.1 billion during Q1 2025.